OriliTM 200 tablet is indicated for the management of moderate to severe pain associated with endometriosis.
Dosage & Administration:
OriliTM 150 tablet: Initial treatment with Elagolix 150 mg once daily up to 24 months. But, in case of moderate hepatic impairment, up to 6 months treatment is recommended.
OriliTM 200 tablet: Initial treatment with elagolix 200 mg twice daily up to 6 months (with coexisting dyspareunia). Treatment with elagolix 200 mg should not exist more than 6 months as it may decrease bone mineral density (BMD). In case of moderate to severe hepatic impairment elagolix 200 mg is not recommended.
OriliTM 200 tablet: Each box contains 12 tablets in alu-alu blister strip.